Vertex Pharmaceuticals Incorporated (LON:0QZU)

Vertex Pharmaceuticals Statistics

Total Valuation

LON:0QZU has a market cap or net worth of GBP 90.85 billion. The enterprise value is 83.16 billion.

Market Cap	90.85B
Enterprise Value	83.16B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	254.03M
Shares Outstanding	n/a
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	-0.58%
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	94.83%
Float	253.26M

Valuation Ratios

The trailing PE ratio is 30.93 and the forward PE ratio is 24.82.

PE Ratio	30.93
Forward PE	24.82
PS Ratio	10.19
PB Ratio	6.55
P/TBV Ratio	7.13
P/FCF Ratio	38.29
P/OCF Ratio	33.67
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.74, with an EV/FCF ratio of 35.04.

EV / Earnings	28.31
EV / Sales	9.26
EV / EBITDA	21.74
EV / EBIT	23.71
EV / FCF	35.04

Financial Position

The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.11.

Current Ratio	2.90
Quick Ratio	2.24
Debt / Equity	0.11
Debt / EBITDA	0.40
Debt / FCF	0.64
Interest Coverage	352.44

Financial Efficiency

Return on equity (ROE) is 22.54% and return on invested capital (ROIC) is 29.61%.

Return on Equity (ROE)	22.54%
Return on Assets (ROA)	12.16%
Return on Invested Capital (ROIC)	29.61%
Return on Capital Employed (ROCE)	21.52%
Weighted Average Cost of Capital (WACC)	5.89%
Revenue Per Employee	1.39M
Profits Per Employee	458,942
Employee Count	6,400
Asset Turnover	0.50
Inventory Turnover	3.85

Taxes

In the past 12 months, LON:0QZU has paid 512.67 million in taxes.

Income Tax	512.67M
Effective Tax Rate	14.86%

Stock Price Statistics

The stock price has decreased by -2.82% in the last 52 weeks. The beta is 0.32, so LON:0QZU's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-2.82%
50-Day Moving Average	467.43
200-Day Moving Average	437.11
Relative Strength Index (RSI)	51.32
Average Volume (20 Days)	1,162

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.16

Income Statement

In the last 12 months, LON:0QZU had revenue of GBP 8.92 billion and earned 2.94 billion in profits. Earnings per share was 11.38.

Revenue	8.92B
Gross Profit	4.79B
Operating Income	3.48B
Pretax Income	3.45B
Net Income	2.94B
EBITDA	3.62B
EBIT	3.48B
Earnings Per Share (EPS)	11.38

Balance Sheet

The company has 4.91 billion in cash and 1.51 billion in debt, with a net cash position of 7.64 billion.

Cash & Cash Equivalents	4.91B
Total Debt	1.51B
Net Cash	7.64B
Net Cash Per Share	n/a
Equity (Book Value)	13.87B
Book Value Per Share	54.60
Working Capital	5.45B

Cash Flow

In the last 12 months, operating cash flow was 2.70 billion and capital expenditures -325.14 million, giving a free cash flow of 2.37 billion.

Operating Cash Flow	2.70B
Capital Expenditures	-325.14M
Free Cash Flow	2.37B
FCF Per Share	n/a

Margins

Gross margin is 53.67%, with operating and profit margins of 39.06% and 32.94%.

Gross Margin	53.67%
Operating Margin	39.06%
Pretax Margin	38.69%
Profit Margin	32.94%
EBITDA Margin	40.55%
EBIT Margin	39.06%
FCF Margin	26.61%

Dividends & Yields

LON:0QZU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.04%
Shareholder Yield	-0.04%
Earnings Yield	3.23%
FCF Yield	2.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0QZU has an Altman Z-Score of 11.93 and a Piotroski F-Score of 6.

Altman Z-Score	11.93
Piotroski F-Score	6